Armistice Capital »

Markel Corporation shares owned by Armistice Capital

Quarter-by-quarter ownership of Markel Corporation (MKL) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Markel Corporation

Tip: Access up to 7 years of quarterly data

All positions including Markel Corporation held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Markel Corporation by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $278k 145 1914.07

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Markel Corporation

Vanguard Group
BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
Principal Financial Group
Davis Selected Advisers
Select Equity
Morgan Stanley
State Street Corporation
Robeco Investment Management
Kempen Capital Management
Geode Capital Management
Davenport & Co
Baillie Gifford & Co
T. Rowe Price Investment Management

View all funds holding Markel Corporation